The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors

Emerging evidence supports the important role of the tumor microbiome in oncogenesis, cancer immune phenotype, cancer progression, and treatment outcomes in many malignancies. In this study, we investigated the metastatic melanoma tumor microbiome and potential roles in association with clinical out...

Descripción completa

Detalles Bibliográficos
Autores principales: Wheeler, Caroline E., Coleman, Samuel S., Hoyd, Rebecca, Denko, Louis, Chan, Carlos H.F., Churchman, Michelle L., Denko, Nicholas, Dodd, Rebecca D., Eljilany, Islam, Hardikar, Sheetal, Husain, Marium, Ikeguchi, Alexandra P., Jin, Ning, Ma, Qin, McCarter, Martin D., Osman, Afaf E.G., Robinson, Lary A., Singer, Eric A., Tinoco, Gabriel, Ulrich, Cornelia M., Zakharia, Yousef, Spakowicz, Daniel, Tarhini, Ahmad A., Tan, Aik Choon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245822/
https://www.ncbi.nlm.nih.gov/pubmed/37292921
http://dx.doi.org/10.1101/2023.05.24.542123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245822/
https://www.ncbi.nlm.nih.gov/pubmed/37292921
http://dx.doi.org/10.1101/2023.05.24.542123

Ejemplares similares